1.
Beltran G, Stuckey WJ: Nuclear lobulation and cytoplasmic fibrils in leukemic plasma cells. Am J Clin Pathol 1972;58:159-164.
2.
Djaldetti M, Lewinski UH: Nuclear hypersegmentation in the myeloma cells of a patient with multiple myeloma. Scand J Haematol 1983;31:144-148.
3.
Kurabayashi H, Miyawaki S, Murakami H, Nemoto K, Sawamura M, Kubota K, Naruse T, Tsuchiya J: Ultrastructure of multinucleated giant myeloma cells: report of one case, Am J Hematol 1989;31:284-285.
4.
Buss DH, Reynolds GD, Cooper MR: Multiple myeloma associated with multilobated plasma cell nuclei. Virchows Arch B Cell Pathol Incl Mol Pathol 1988;55:287-292.
5.
Zukerberg LR, Ferry JA, Conlon M, Harris NL: Plasma cell myeloma with cleaved, multilobated, and monocytoid nuclei. Am J Clin Pathol 1990;93:657-661.
6.
Islam A, Noyes S, Henderson ES: A case of aggressive multiple myeloma with convoluted and multilobated plasma cell nuclei and no visible nucleoli. Br J Haematol 1990;76:306-307.
7.
Olujohungbe AB, Brace WD, Laversuch CJ, Cotter FE, Reid CD: Sternal-clavicular plasmacytomas with atypical morphology. Br J Haematol 1991;78:290-291.
8.
Richter J, Swedin A, Olofsson T, Johansson B, Akerman M, Winqvist I: Aggressive course of primary plasma cell leukemia with unusual morphological and cytogenetic features. Ann Hematol 1995;71:307-310.
9.
Fuchs R, Reisner R, Hellerich U: Multilobulated multiple myeloma - a rare morphological type. Onkologie 1995;18:580-584.
10.
Go JH, Ko YH, Ree HJ: Cleaved variant of plasmacytoma with myelomonocytic differentiation - immunohistochemical and ultrastructural studies. J Korean Med Sci 1997;12:443-446.
11.
Invernizzi R, Perfetti V: A case of multiple myeloma with multilobated plasma cell nuclei. Haematologica 1998;83:851.
12.
Yeh YA, Pappas AA, Flick JT, Butch AW: A case of aggressive multiple myeloma with cleaved, multilobated, and monocytoid nuclei, and no serum monoclonal gammopathy. Ann Clin Lab Sci 2000;30:283-288.
13.
Metzgeroth G, Sick Ch, Maywald O, Schatz M, Kuhn Ch, Hehlmann R, Hastka J: Multilobated nuclei in Waldenström's macroglobulinaemia. Eur J Haematol 2003;71:307-310.
14.
John S, Feroze M, Supriya NK, Aisabi KA: Plasma cell leukemia with pleomorphic plasma cells - a case report. Indian J Pathol Microbiol 2006;49:438-439. Erratum in: Indian J Pathol Microbiol 2007;50:45.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or...
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.